| No. | Case | Principal Investigator |
| 1 | The exploration of multiple serum biomarker panel in autoimmune thyroid disease | Jiunn-Diann Lin |
| 2 | Unveiling the Role of Nuclear SPHK2 in Lung Adenocarcinoma | Tsung-Ching Lai |
| 3 | Developing Amino Acid-Modified Pluronic Hydrogels to Enable Topical Intratumoral Drug Delivery for difficult gliomas in children | Tai-Tong Wong |
| 4 | Applying an establishing translational research and technology platform for the development of ameliorated new therapy strategies in childhood gliomas | Tai-Tong Wong |
| 5 | Radiogenomics and Bioinformatic Platform for CNS Germ Cell Tumor: a Multi-institute and Multi-discipline Integrated Study | Tai-Tong Wong |
| 6 | Potential targets in tumor microenvironment (TME), immune microenvironment (TIME), and radiation-induced TME/TIME changes for novel radiation risk-reduction multimodal therapy of malignant pediatric brain tumors–a continuation study | Tai-Tong Wong |
| 7 | Molecular diagnosis and classification of childhood brain tumor in Taiwan. | Tai-Tong Wong |
| 8 | Potential targets in tumor microenvioronment (TME), immune microenvironment (TIME), and radation-induced TIME changes for novel radiation risk-reduction multimodal therpy of malignant peidatric brain tumors | Tai-Tong Wong |
| 9 | Investigating the Therapeutic Effect and Molecular Mechanisms of Antroquinonol, a Derivative from Antrodia cinnamomea, in Blocking L1CAM/RET-Mediated Drug Resistance and Immune Suppression in Renal Cell Carcinoma: A Translational Medical Study Targeting Drug-Resistant Renal Cell Carcinoma | Lee, Wei-Jiunn |
| 10 | Real-World Analysis of MET Protooncogene Alterations in Advanced Solid Tumors in Taiwan Using the National Biobank Consortium of Taiwan (NBCT) Data Platform | Wang Yu Chieh |
| 11 | 【Biobank and CRISPR基因編輯核心實驗室】Analyzing independent of oxygenation state of the E3 Ubiquitin Protein Ligase SIAH regulate hypoxia-inducible factor (HIF)-1α in drug-resistant colorectal cancer tumor microenvironment | Tung-Cheng Chang |
| 12 | The Association Between Molecular Subtypes of Endometrial Cancer and Lymph Node Metastasis: A Single-Center Retrospective Cohort Study (20202025) | Timothy Chiu |
| 13 | Identification of Differentially Expressed Genes for Chimeric Antigen Receptor T- Cell Therapy in Leiomyosarcoma, Endometrial and Ovarian Clear Cell Carcinoma | J. Timothy Qiu |
| 14 | Mechanistic exploration of TAMs/CXCL6/CXCLR2 OncoImmune axis in contributing to radiaoresistance in hepatocellular carcinoma | TSAI,JO TING |
| 15 | Investigation of The Mechanistic Role and Translational Application of BTK to Target Ferroptosis Vulnerability in Drug-Tolerant Persister Esophageal Cancer | Yao-Yu Hsieh |
| 16 | Significance of dual targeting on BTK/BCL2L11 axis in the context of Cisplatin-Tolerant Persister Esophageal Cancer | Yao-Yu Hsieh |
| 17 | Developing a Risk Prediction Model Using Precision Medicine Approaches for Cisplatin-Induced Ototoxicity in Pediatric Cancer Patients | Wan-Ling Ho |
| 18 | Secreted phospholipase A2 G2D may serve as a novel therapeutic and prognostic biomarker in cancer patients | Liu Yun-Ru |
| 19 | A Longitudinal Multi-Omic Study of Breast Cancer Risk: Integrating Dynamic Metabolomic and Epigenomic Changes with Genetic Susceptibility in the Taiwan Biobank | Wen-Feng Wu |
| 20 | Verification of BRCA1/2 pathogenic mutation genes | Chang Wei, Li |
| 21 | Using Anti-3-nitrotyrosine Modified Peptide Adduct Autoantibodies to Import Machine Learning for Predicting Coronary Artery Stenosis in Taiwanese Patients with Coronary Artery Disease | SHOU CHENG LU |
